Status:
TERMINATED
Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.
Lead Sponsor:
HCA International Limited
Conditions:
Metastatic Brain Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the use of a scalp sparing technique of radiotherapy treatment designed to treat the whole brain. Current treatment methods to treat the whole brain with radiotherapy result in complete...
Detailed Description
Rationale for conducting the SPARE study: The purpose of this study is to evaluate the effect of delivering WBRT via the VMAT method on hair loss and subsequent re-growth. Hair loss has been found to...
Eligibility Criteria
Inclusion
- Adults over 18
- Positive cancer diagnosis
- Either proven brain metastasis or prophylaxis for primary lung cancer
- Have no epilating chemotherapy planned
- Basic understanding of English
Exclusion
- Previous whole brain radiotherapy
- Pregnant females
- Unable to give informed consent
- Urgent cases that need same or next day treatment when referred
Key Trial Info
Start Date :
August 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT02213536
Start Date
August 1 2015
End Date
February 20 2019
Last Update
February 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Harley Street Clinic
London, United Kingdom, W1G 8PP